$320 Million is the total value of Argyle Capital Management Inc.'s 129 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 38.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INTC | Buy | Intel Corp | $6,195,000 | -2.0% | 120,283 | +1.3% | 1.93% | -7.7% |
| RDSA | Buy | Royal Dutch Shell Plcspons adr a | $5,859,000 | +1259.4% | 72,536 | +650.0% | 1.83% | +1178.3% |
| VZ | Buy | Verizon Communications | $4,722,000 | -2.9% | 90,879 | +0.9% | 1.47% | -8.6% |
| MDT | New | Medtronic Inc | $4,500,000 | – | 43,500 | +100.0% | 1.40% | – |
| DUK | New | Duke Energy Corp | $4,414,000 | – | 42,078 | +100.0% | 1.38% | – |
| T | Buy | AT&T Inc | $3,879,000 | -7.3% | 157,670 | +1.7% | 1.21% | -12.7% |
| ENB | Buy | Enbridge Inc | $3,690,000 | -0.3% | 94,427 | +1.6% | 1.15% | -6.1% |
| PPL | Buy | PPL Corp | $2,871,000 | +10.1% | 95,515 | +2.1% | 0.90% | +3.8% |
| FISV | Buy | Fiserv Inc | $2,430,000 | -0.1% | 23,413 | +4.5% | 0.76% | -5.8% |
| MANT | Buy | ManTech Intl Corpcl a | $2,154,000 | -2.3% | 29,534 | +1.7% | 0.67% | -7.9% |
| PSX | Buy | Phillips 66 | $1,829,000 | +7.8% | 25,235 | +4.1% | 0.57% | +1.6% |
| HAL | Buy | Halliburton Co | $1,506,000 | +7.3% | 65,850 | +1.4% | 0.47% | +1.1% |
| SLB | Buy | Schlumberger Ltd | $1,260,000 | +2.6% | 42,083 | +1.6% | 0.39% | -3.4% |
| GE | Buy | General Electric Co | $1,093,000 | -7.5% | 11,574 | +0.9% | 0.34% | -12.8% |
| TRP | New | TC Energy Corp | $1,040,000 | – | 22,350 | +100.0% | 0.32% | – |
| XOM | Buy | Exxon Mobil Corp | $953,000 | +8.8% | 15,569 | +4.5% | 0.30% | +2.4% |
| VMW | New | VMware Inc | $654,000 | – | 5,648 | +100.0% | 0.20% | – |
| DLX | New | Deluxe Corp | $209,000 | – | 6,500 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 42 | Q3 2023 | 5.3% |
| Merck & Co Inc | 42 | Q3 2023 | 3.2% |
| Pfizer Inc | 42 | Q3 2023 | 2.8% |
| Amgen Inc | 42 | Q3 2023 | 2.9% |
| Intel Corp | 42 | Q3 2023 | 3.1% |
| Bristol Myers Squibb Co | 42 | Q3 2023 | 2.9% |
| Paychex Inc | 42 | Q3 2023 | 2.3% |
| Lilly Eli Co | 42 | Q3 2023 | 4.4% |
| Verizon Communications | 42 | Q3 2023 | 2.6% |
| Johnson & Johnson | 42 | Q3 2023 | 2.2% |
View Argyle Capital Management Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-07-27 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-20 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-01-25 |
View Argyle Capital Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.